Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: A single-center experience

Rim Frikha, Tarek Rebaï, Lobna Ben Mahmoud, Fakher Frikha, M. Mdhaffar, Imen Frikha, Moez Elloumi

Journal of Oncology Pharmacy Practice · 2018 · 10 citations · 11 references

Abstract

Our findings suggest that C677T polymorphism of MTHFR seems to be a good marker for MTX-related toxicity in ALL.

References

11